$21.30 -1.19 (-5.27%) Akorn Inc - NASDAQ

Jan. 17, 2017 | 03:30 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 21.30
Trade Time: Jan 17 03:30 PM Eastern Daylight Time
Change: -1.19 (-5.27%)
Prev Close: 22.48
Open: 22.25
Bid: 21.29
Ask: 21.30
  1. Investing To Win: How To Use IBD's EPS, RS Ratings Correctly

    Investors Business Daily | Dec. 7, 2016 | 13:56PM EST
  2. Drug Stocks Topple On Donald Trump's Pledge To Bring Down Drug Prices

    Investors Business Daily | Dec. 7, 2016 | 11:36AM EST
  3. Drug Stocks Topple On Donald Trump's Pledge To Bring Down Drug Prices

    Investors Business Daily | Dec. 7, 2016 | 11:36AM EST
  4. Magic Recipe Movers - The Trump Effect

    TalkMarkets | Nov. 13, 2016 | 22:45PM EST
  5. Stocks Remain Indecisive; Jack In The Box, Fitbit Score Big Gains

    Investors Business Daily | Aug. 4, 2016 | 14:29PM EST
  6. Stock Futures Up, Europe Rallies On BOE Vote; Monster On Deck

    Investors Business Daily | Aug. 4, 2016 | 07:58AM EST
  7. John Paulson Bulks Up Health Care Bet

    GuruFocus | Feb. 17, 2016 | 17:02PM EST
  8. Top-Notch Funds Buying Constellation, Northrop Grumman

    IBD | Jan. 8, 2016 | 17:56PM EST
  9. Piper Jaffray: Akorn's Stock Will Be Delisted In 2016

    Benzinga | Dec. 18, 2015 | 11:18AM EST
  10. Piper Jaffray Makes 15 'Provocative' Predictions For Biopharma Sector In 2016

    Benzinga | Dec. 18, 2015 | 10:52AM EST
  11. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio

    Benzinga | Oct. 27, 2015 | 03:23AM EST
  12. Biotechs, Medicals Whacked As Nasdaq Trades Near Day's Low

    IBD | Oct. 6, 2015 | 12:23PM EST
  13. Apricus Reports Top-Line Phase 2a Data for RayVa(TM), Its Topical Treatment for Raynaud's Phenomenon

    Benzinga | Sep. 17, 2015 | 06:00AM EST
  14. The Coming Drug-Patent Cliff Is Pushing This Portfolio Up

    Benzinga | Aug. 20, 2015 | 13:48PM EST
  15. Akorn's

    IBD | Aug. 4, 2015 | 17:41PM EST
Trading Center